DK0403150T3 - Fremgangsmåde til fremstilling af tigogenin-beta-cellobiosid - Google Patents

Fremgangsmåde til fremstilling af tigogenin-beta-cellobiosid

Info

Publication number
DK0403150T3
DK0403150T3 DK90306143.0T DK90306143T DK0403150T3 DK 0403150 T3 DK0403150 T3 DK 0403150T3 DK 90306143 T DK90306143 T DK 90306143T DK 0403150 T3 DK0403150 T3 DK 0403150T3
Authority
DK
Denmark
Prior art keywords
tigogenin
cellobioside
beta
preparation
synthesis
Prior art date
Application number
DK90306143.0T
Other languages
English (en)
Inventor
Frank John Urban
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0403150T3 publication Critical patent/DK0403150T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catalysts (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK90306143.0T 1989-06-13 1990-06-06 Fremgangsmåde til fremstilling af tigogenin-beta-cellobiosid DK0403150T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/365,588 US5010185A (en) 1989-06-13 1989-06-13 Processes for tigogenin beta-cellobioside

Publications (1)

Publication Number Publication Date
DK0403150T3 true DK0403150T3 (da) 1995-01-16

Family

ID=23439483

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90306143.0T DK0403150T3 (da) 1989-06-13 1990-06-06 Fremgangsmåde til fremstilling af tigogenin-beta-cellobiosid

Country Status (23)

Country Link
US (1) US5010185A (da)
EP (1) EP0403150B1 (da)
JP (1) JPH0637514B2 (da)
KR (1) KR920002146B1 (da)
AT (1) ATE114155T1 (da)
AU (1) AU619986B2 (da)
CA (1) CA2018722A1 (da)
CZ (1) CZ279909B6 (da)
DD (1) DD295164A5 (da)
DE (1) DE69014152T2 (da)
DK (1) DK0403150T3 (da)
ES (1) ES2063269T3 (da)
FI (1) FI902937A0 (da)
HU (1) HU210689B (da)
IE (1) IE64057B1 (da)
IL (1) IL94650A (da)
NO (1) NO902600L (da)
NZ (1) NZ234028A (da)
PL (3) PL163258B1 (da)
PT (1) PT94337A (da)
RU (1) RU2042688C1 (da)
YU (1) YU47515B (da)
ZA (1) ZA904527B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294703A (en) * 1992-05-01 1994-03-15 Eastman Kodak Company Process for preparing α-D-cellobiose octaacetate
CZ331094A3 (en) * 1992-06-26 1995-09-13 Pfizer Steroidal glycosides and their use for treating hypercholesterolemia and atherosclerosis
ATE158299T1 (de) * 1992-06-26 1997-10-15 Pfizer Verfahren zur herstellung von per-acylierten glykosiden
WO1994000478A1 (en) * 1992-06-26 1994-01-06 Pfizer Inc. Steroidal beta-o-cellobioside heptaalkanoate process
US5530107A (en) * 1992-10-15 1996-06-25 Pfizer Inc. Method for making steroidal peracyl glycosides
CA2161239A1 (en) * 1993-04-28 1994-11-10 Douglas J.M. Allen Spirostanyl glycosidal crystalline monohydrate
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
ES2074006B1 (es) * 1993-07-05 1996-03-16 Pfizer Glicosidos esteroidales para tratar hipercolesterolemia.
AU2003248057A1 (en) * 2002-07-12 2004-02-02 Shinichiro Nishimura Simple process for production of zeolite analogues functioning as acid catalysts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia

Also Published As

Publication number Publication date
EP0403150A2 (en) 1990-12-19
HU210689B (en) 1995-06-28
CZ279909B6 (cs) 1995-08-16
PL163258B1 (pl) 1994-02-28
YU47515B (sh) 1995-10-03
AU619986B2 (en) 1992-02-06
IE902101A1 (en) 1991-01-02
ES2063269T3 (es) 1995-01-01
KR920002146B1 (ko) 1992-03-12
ATE114155T1 (de) 1994-12-15
KR910000779A (ko) 1991-01-30
PL163259B1 (pl) 1994-02-28
HU903816D0 (en) 1990-11-28
RU2042688C1 (ru) 1995-08-27
US5010185A (en) 1991-04-23
DE69014152T2 (de) 1995-03-23
EP0403150B1 (en) 1994-11-17
PT94337A (pt) 1991-02-08
JPH0331297A (ja) 1991-02-12
HUT54708A (en) 1991-03-28
CZ289090A3 (en) 1995-04-12
IE64057B1 (en) 1995-07-12
NO902600D0 (no) 1990-06-12
AU5707990A (en) 1991-08-01
NZ234028A (en) 1991-10-25
IE902101L (en) 1990-12-13
IL94650A (en) 1994-11-11
DD295164A5 (de) 1991-10-24
IL94650A0 (en) 1991-04-15
FI902937A0 (fi) 1990-06-12
PL289135A1 (en) 1992-02-24
PL289136A1 (en) 1992-02-24
DE69014152D1 (de) 1994-12-22
ZA904527B (en) 1992-01-29
YU114590A (en) 1991-10-31
CA2018722A1 (en) 1990-12-13
JPH0637514B2 (ja) 1994-05-18
NO902600L (no) 1990-12-14
PL285593A1 (en) 1991-07-01
EP0403150A3 (en) 1992-06-17
PL163219B1 (pl) 1994-02-28

Similar Documents

Publication Publication Date Title
DK0657428T3 (da) Fremstilling af 3,4,4-trisubstituerede-piperidinyl-N-alkylcarboxylater og mellemprodukter, der er egnede som opioidantagonister
NO901338L (no) Fremgangsmaate til sammenfoeyning av elementer, ved fremstilling av termostrukturelle kompositt materialdeler.
DK0403150T3 (da) Fremgangsmåde til fremstilling af tigogenin-beta-cellobiosid
DE69001623T2 (de) Verfahren zur Herstellung von Fluor-oxy-fluorsulfonylverbindungen durch direkte Fluorierung von Fluor-beta-sultonen.
DK0417680T3 (da) Fremgangsmåde til fremstilling af 1,1,1,2-tetrafluorethan
DK3095A (da) Fremgangsmåde til fremstilling af 2-aza-4-(alkoxycarbonyl)spiro[4,5]decan-3-oner
DK0407961T3 (da) Fremgangsmåde til fremstilling af 1,1,1-trifluor-2-chlorethan
DE69013132D1 (de) Verfahren zur Herstellung von Octa-2,7-dien-1-ol.
EP0861838A3 (en) Process and intermediates for preparing cryptophycin compounds
DE59007794D1 (de) Verfahren zur Herstellung von 2-Chlor-5-chlormethyl-pyridin und neue Zwischenprodukte.
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK1075473T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer
DK0401591T3 (da) Støtteforbindsmaterialer med lav tendens til skumdannelse
DK1140785T3 (da) Fremgangsmåde til fremstilling af polyhalogenerede paratrifluormethylaniliner
DE69007028D1 (de) Verfahren zur Herstellung von 3,4-Epoxybutyrat und Zwischenprodukte dafür.
ES2016975B3 (es) Compuestos quimicos.
DK0377437T3 (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-piperidinylpyrimidin-3-N-oxid
DK0761657T3 (da) Fremgangsmåde til fremstilling af benzylsubstituerede rhodaninderivater
JPS52122398A (en) Preparation of 02 , 3'-cyclopyrimidinenucleosides
DE69302950D1 (de) Verfahren zur Herstellung von Stahlblechen und Stahlbleche, nach diesem Verfahren hergestellt
FI102166B1 (fi) Menetelmä N,N-dimetyyliaminometyyliaryyliyhdisteiden valmistamiseksi
DK0743961T3 (da) Fremgangsmåde til fremstilling af lignocellulose-legemer
DK93884D0 (da) Fremgangsmade til fremstilling af 1,5-dibeskyttede-1,5,10-triazadecaner, mellemprodukter derfor samt disses fremstilling
DE59009161D1 (de) Positiv arbeitendes strahlungsempfindliches Gemisch, enthaltend einen mehrfunktionellen alpha-Diazo-beta-ketoester, Verfahren zu dessen Herstellung und strahlungsempfindliches Aufzeichnungsmaterial enthaltend dieses Gemisch.
IT1218557B (it) Processo per l'utilizzazione di materiali vegetali di scarto mediante fermentazioni aerobiche controllate precedute da pretrattamenti chimici